Learn how a 25% Pharma tariff could raise U.S. drug costs by nearly $51 billion annually and impact prices significantly.

Guardant Health, Inc. (NASDAQ: GH), a $5.6 billion market cap pioneer in precision oncology, has entered into a strategic collaboration with global pharmaceutical giant Pfizer Inc. (NYSE ...

BofA lowered the firm’s price target on Pfizer (PFE) to $26 from $29 and keeps a Neutral rating on the shares. For Q1, the firm’s total revenue estimates decline by 2% due to Part D ...

If your Windows computer is crashing unexpectedly and showing you a blue screen error, there's now a fix for that. As BleepingComputer reports, Windows updates pushed in March and April are ...

The migration of dozens of moose in Sweden to their summer grazing grounds has followed the same path for thousands of years. Now, millions across the globe are getting a chance to experience the ...

The New Orleans Saints' logo is one of the best in the NFL, and it will stay that way after a court ruled in their favor on a lawsuit centered around the fleur-de-lis symbol. The U.S. Court of ...

Tuesday was a relatively uneventful news day for Pfizer, especially following the pharmaceutical giant's disclosure on Monday that it halted the development of its investigational weight loss drug ...

Novavax recipients had 1.7 symptoms on average vs. 2.8 for Pfizer-BioNTech in SHIELD-Utah. 24.2% of Novavax recipients had Grade 2+ symptoms vs. 43.8% of Pfizer-BioNTech recipients. Feel unsure ...

Shares of Viking Therapeutics (VKTX) and Structure Therapeutics (GPCR) are on the rise on Monday after Pfizer (PFE) announced its decision to discontinue development of danuglipron, an oral ...

Pfizer Inc. has said it will discontinue development of its closely watched obesity pill, danuglipron, dealing a severe blow to the company’s ambitions to compete in the rapidly growing weight-loss ...